SecProbe.io

CORRESP
1
filename1.htm

        January 6, 2025

        Via EDGAR

        U.S. Securities and Exchange Commission

        Division of Corporation Finance

        100 F Street, N.E.

        Washington, DC 20549

        Attn: Doris Gama

                Re:

                Cartesian Therapeutics, Inc.

                Registration Statement on Form S-3 (the “Registration Statement”)

                File No. 333-283809

        Ladies and Gentlemen:

        Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cartesian Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be
          accelerated to 4:00 p.m., Eastern Time, on January 8, 2025, or as soon as practicable thereafter.

        Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Griffiths by telephone
          when this request for acceleration has been granted.

                Very truly yours,

                CARTESIAN THERAPEUTICS, INC.

                By:

                /s/ Carsten Brunn

                Name:

                Carsten Brunn

                Title:

                President and Chief Executive Officer

                cc:

                Brian K. Rosenzweig, Covington & Burling LLP

                Sarah C. Griffiths, Covington & Burling LLP